216 related articles for article (PubMed ID: 2932484)
1. Dexamethasone suppression test and sleep deprivation in endogenous depression.
Kuhs H
J Affect Disord; 1985 Sep; 9(2):121-6. PubMed ID: 2932484
[TBL] [Abstract][Full Text] [Related]
2. Dexamethasone suppression test combined with total sleep deprivation in depressed patients.
Kasper S; Moises HW; Beckmann H
Psychiatr Clin (Basel); 1983; 16(1):17-25. PubMed ID: 6844658
[TBL] [Abstract][Full Text] [Related]
3. Plasma corticosterone and cortisol following dexamethasone in psychiatric patients.
Arana GW; Wilens TE; Baldessarini RJ
Psychoneuroendocrinology; 1985; 10(1):49-60. PubMed ID: 4001277
[TBL] [Abstract][Full Text] [Related]
4. Number of cortisol time-points and dexamethasone suppression test sensitivity for major depression.
Extein I; Pottash AL; Gold MS
Psychoneuroendocrinology; 1985; 10(3):281-8. PubMed ID: 4059475
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study.
Stokes PE; Stoll PM; Koslow SH; Maas JW; Davis JM; Swann AC; Robins E
Arch Gen Psychiatry; 1984 Mar; 41(3):257-67. PubMed ID: 6367690
[TBL] [Abstract][Full Text] [Related]
6. Clinical variables and hypothalamic-pituitary-adrenal function in depression. The importance of mood reactivity.
Lemus CZ; Asnis GM; Halbreich U; Harkavy Friedman JM; Van Praag HM; Rubinson E; Eisenberg J
J Affect Disord; 1987; 12(3):219-21. PubMed ID: 2956306
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine aspects of primary endogenous depression. II. Serum dexamethasone concentrations and hypothalamic-pituitary-adrenal cortical activity as determinants of the dexamethasone suppression test response.
Poland RE; Rubin RT; Lesser IM; Lane LA; Hart PJ
Arch Gen Psychiatry; 1987 Sep; 44(9):790-5. PubMed ID: 3632252
[TBL] [Abstract][Full Text] [Related]
8. Cortisol suppression and circadian rhythm in endogenous depression: a preliminary report.
Lee MA; Taylor MA
Biol Psychiatry; 1983 Oct; 18(10):1127-32. PubMed ID: 6652153
[TBL] [Abstract][Full Text] [Related]
9. Platelet MAO activity and the dexamethasone suppression test in bipolar depression.
Bagdy G; Rihmer Z; Frecska E; Szádóczky E; Arató M
Psychoneuroendocrinology; 1986; 11(1):117-20. PubMed ID: 3704065
[TBL] [Abstract][Full Text] [Related]
10. Association performance and the DST.
Demeter E; Rihmer Z; Arato M; Frecska E
Psychiatry Res; 1986 Jul; 18(3):289-90. PubMed ID: 3749388
[No Abstract] [Full Text] [Related]
11. Hypothalamo-pituitary-adrenal activity in endogenously depressed post-traumatic stress disorder patients.
Halbreich U; Olympia J; Carson S; Glogowski J; Yeh CM; Axelrod S; Desu MM
Psychoneuroendocrinology; 1989; 14(5):365-70. PubMed ID: 2813658
[TBL] [Abstract][Full Text] [Related]
12. The dexamethasone suppression and metyrapone tests in depression.
Morphy MA; Fava GA; Perini GI; Molnar G; Zielezny M; Lisansky J
Psychiatry Res; 1985 Jun; 15(2):153-8. PubMed ID: 3862146
[TBL] [Abstract][Full Text] [Related]
13. Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression. Implications for pathophysiology of DST nonsuppression.
Holsboer F; von Bardeleben U; Wiedemann K; Müller OA; Stalla GK
Biol Psychiatry; 1987 Feb; 22(2):228-34. PubMed ID: 3028512
[No Abstract] [Full Text] [Related]
14. Decreased dexamethasone suppression in endogenously depressed patients with normal basal plasma levels of cortisol.
Halbreich U; Naor S; Asnis G; Gasparini F; Goldstein S; Vital-Herne J; Kang BJ
Biol Psychiatry; 1986 Dec; 21(14):1434-7. PubMed ID: 3790627
[No Abstract] [Full Text] [Related]
15. Weekly monitoring of dexamethasone suppression response in depression: its relationship to change of body weight and psychopathology.
Gerken A; Maier W; Holsboer F
Psychoneuroendocrinology; 1985; 10(3):261-71. PubMed ID: 4059474
[TBL] [Abstract][Full Text] [Related]
16. Plasma cortisol and 11-deoxycortisol activity in depressed patients and normal volunteers.
Schweitzer I; Tuckwell VM; Maguire KP; Tiller JW; Harrison LC; Davies BM
Psychoneuroendocrinology; 1991; 16(5):375-82. PubMed ID: 1805291
[TBL] [Abstract][Full Text] [Related]
17. Cortisol and corticosterone response after syn-corticotropin in relationship to dexamethasone suppressibility of cortisol.
Gerken A; Holsboer F
Psychoneuroendocrinology; 1986; 11(2):185-94. PubMed ID: 3018821
[TBL] [Abstract][Full Text] [Related]
18. Dexamethasone suppression test in diagnosis of depressive illness.
Hayes PE; Ettigi P
Clin Pharm; 1983; 2(6):538-45. PubMed ID: 6140096
[TBL] [Abstract][Full Text] [Related]
19. The dexamethasone suppression test in depressive, non-depressive and schizoaffective psychosis.
Coccaro EF; Prudic J; Rothpearl A; Nurnberg HG
J Affect Disord; 1985 Sep; 9(2):107-13. PubMed ID: 2932482
[TBL] [Abstract][Full Text] [Related]
20. The dexamethasone suppression test in prepubertal depressed children.
Weller EB; Weller RA; Fristad MA; Preskorn SH; Teare M
J Clin Psychiatry; 1985 Dec; 46(12):511-3. PubMed ID: 4066616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
